Home › Immune System and Disorders › Tennessee › Nashville
Immune System and Disorders clinical trials in Nashville, TN
5 studies for Immune System and Disorders are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RecruitingPhase 1/2
- Vanderbilt University Medical Center, Nashville
Abatacept for the Treatment of Giant Cell Arteritis
RecruitingPhase 3
- Vanderbilt University, Nashville
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
RecruitingPhase 3
- Knoxville Kidney Center Pllc, Brentwood · 9 mi away
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
RecruitingPhase 2
- Vanderbilt University, Ingram Cancer Center, Nashville
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RecruitingPhase 2
- Tristar Bone Marrow Transplant, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
About Immune System and Disorders
Your immune system is made up of cells, tissues, and organs that fight infections and diseases. Learn how it works, and about diseases of the immune system.
More about Immune System and Disorders on MedlinePlus
Immune System and Disorders trials in other cities
- Washington, DC13 studies
- New York City, NY12 studies
- Philadelphia, PA10 studies
- Boston, MA10 studies
- Atlanta, GA9 studies
- Portland, OR9 studies
- Houston, TX9 studies
- Los Angeles, CA8 studies
- Cleveland, OH8 studies
- Chicago, IL8 studies
- Cedar Rapids, IA6 studies
- Seattle, WA6 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer96 studies
- Breast Cancer79 studies
- Metastatic Cancer69 studies
- Colorectal Cancer68 studies
- Cancer (all types)65 studies
- Ovarian Cancer48 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Pancreatic Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Endometrial Cancer37 studies
- Melanoma32 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.